Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2026-05-30 @ 5:52 AM
Study NCT ID:
NCT01414166
Status:
TERMINATED
Last Update Posted:
2015-05-13
First Post:
2011-08-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0524A-108
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None